Delivery Order SPE2DB24D2100-SPE2DB25FBGMP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,030.31 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count). The contract, which became effective on May 20, 2025, with completion by May 21, 2025, is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalers (60-count) on September 2, 2025, with ultimate completion by September 3, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction typical of routine pharmaceutical supply replenishment orders. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its...
- The Defense Logistics Agency awarded a $1,564.83 delivery order to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler products on June 2, 2025, with an ultimate completion date of June 3, 2025. This contract was issued under firm fixed pricing with no set-aside designation, indicating competitive award conditions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child delivery order, this award is...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.08 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.67 to AmerisourceBergen Drug Corp for Wixela 250-50 inhaler (60-count), a combination pharmaceutical product. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.97 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product used in respiratory treatment. This firm fixed price delivery order, issued on April 29, 2025, with an ultimate completion date of April 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for WIXELA 100-50 inhalers in a 60-count configuration. This $1,430.16 firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was made without a set-aside designation, reflecting competitive...
- The Defense Logistics Agency awarded a $10,386.94 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Wixela 250-50 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of September 11, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGMPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,155.90 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the prime contractor at its Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates proven capability in delivering specialized pharmaceutical products across multiple therapeutic domains through competitive procurement processes. This delivery order for respiratory medications aligns with AmerisourceBergen's established role as a primary pharmaceutical supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/19/25 |